UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plasmonic Selection of ssDNA Aptamers against Fibroblast Growth Factor Receptor

ACS combinatorial science, 2019-08, Vol.21 (8), p.578-587

2019

Volltextzugriff (PDF)

Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy

Human gene therapy, 2012-10, Vol.23 (10), p.1090-1100

2012

Volltextzugriff (PDF)

Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study

The Lancet (British edition), 2011-12, Vol.378 (9808), p.1997-2004

2011

Volltextzugriff (PDF)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer

Turkish journal of haematology, 2023-02, Vol.40 (1), p.1-10

2023

Volltextzugriff (PDF)

Correction: Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells

PloS one, 2021-01, Vol.16 (1), p.e0246112-e0246112

2021

Volltextzugriff (PDF)

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D

Frontiers in immunology, 2020, Vol.11, p.40-40

2020

Volltextzugriff (PDF)

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Blood, 2008-03, Vol.111 (6), p.3155-3162

2008

Volltextzugriff (PDF)

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

Cytotherapy (Oxford, England), 2010-12, Vol.12 (8), p.1044-1055

2010

Volltextzugriff (PDF)

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma

PloS one, 2015-09, Vol.10 (9), p.e0138248-e0138248

2015

Volltextzugriff (PDF)

Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity

Journal of extracellular vesicles, 2017-12, Vol.6 (1), p.1284449-n/a

2017

Volltextzugriff (PDF)

Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS

Scientific reports, 2019-08, Vol.9 (1), p.11697-11, Article 11697

2019

Volltextzugriff (PDF)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer

Turkish journal of haematology, 2023-03, Vol.40 (1), p.1-10

2023

Volltextzugriff (PDF)

Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer

European journal of immunology, 2019-08, Vol.49 (8), p.1278-1290

2019

Volltextzugriff (PDF)

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

BLOOD, 2021, Vol.138 (Supplement 1), p.4796-4796

2021

Volltextzugriff (PDF)

Identification and strategic targeting of key anti-viral defense mechanisms in Natural Killer cells

JOURNAL OF IMMUNOLOGY, 2018, Vol.200 (1_Supplement), p.169-169.19

2018

Volltextzugriff (PDF)

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma

Cell reports. Medicine, 2022-02, Vol.3 (2), p.100508-100508, Article 100508

2022

Volltextzugriff (PDF)

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells

Cancers, 2019-01, Vol.11 (1), p.69

2019

Volltextzugriff (PDF)

Human immunodeficiency virus type 1 impairs sumoylation

Life science alliance, 2022-06, Vol.5 (6), p.e202101103

2022

Volltextzugriff (PDF)

Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model

The Journal of clinical investigation, 2014-09, Vol.124 (9), p.4067-4081

2014

Volltextzugriff (PDF)

Triticum durum Metallothionein

The Journal of biological chemistry, 2005-04, Vol.280 (14), p.13701-13711

2005

Volltextzugriff (PDF)

Ex vivo expansion of natural killer cells: a question of function

Cytotherapy (Oxford, England), 2011-07, Vol.13 (6), p.767-768

2011

Volltextzugriff (PDF)

Abstract A21: Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer

Cancer immunology research, 2020-04, Vol.8 (4_Supplement), p.A21-A21

2020

Volltextzugriff (PDF)

Abstract A55: Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+ sarcomas and other malignancies

Cancer immunology research, 2020-04, Vol.8 (4_Supplement), p.A55-A55

2020

Volltextzugriff (PDF)

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides

The FASEB journal, 2007-09, Vol.21 (11), p.2664-2671

2007

Volltextzugriff (PDF)

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study

Immunotherapy, 2009-09, Vol.1 (5), p.753-764

2009

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(33)

Publikationsform

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plasmonic Selection of ssDNA Aptamers against Fibroblast Growth Factor Receptor

Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy

Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer

Correction: Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components

Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma

Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet's disease severity

Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer

Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer

CD38 Down-Regulation on Ex Vivo Activated and Expanded NK Cells for Cell Therapy Persists after Infusion

Identification and strategic targeting of key anti-viral defense mechanisms in Natural Killer cells

Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells

Human immunodeficiency virus type 1 impairs sumoylation

Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model

Triticum durum Metallothionein

Ex vivo expansion of natural killer cells: a question of function

Abstract A21: Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer

Abstract A55: Natural killer cells genetically modified to overexpress DNAM-1 exert enhanced antitumor responses against CD112/CD155+ sarcomas and other malignancies

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides

Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study

Suchergebnisse filtern